SION Stock Analysis: Buy, Sell, or Hold?
SION - Sionna Therapeutics, Inc. Common Stock
$49.15
2.02 (4.28%)
▲
5d:
+8.3%
30d:
+11.72%
90d:
+25.53%
HOLD
MODERATE Confidence
Analysis Updated: Jul 31, 2026 12:00 AM ET
Earnings: Aug 10, 2026
6d
Get Alerted When SION Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: SION shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
📊 HOLD: SION shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
In-depth Analysis How we analyze
Valuation Analysis: SION is currently trading at $49.15, which is considered extended relative to its 30-day fair value range of $43.04 to $46.81.
Technical Outlook: Technically, SION is in a uptrend. The price is approaching resistance at $48.57. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation. The stock is showing strong short-term momentum, up 4.3% recently.
Market Sentiment: The stock shows a mixed technical setup (55/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $51.60 (+10.3%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, SION is in a uptrend. The price is approaching resistance at $48.57. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation. The stock is showing strong short-term momentum, up 4.3% recently.
Market Sentiment: The stock shows a mixed technical setup (55/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $51.60 (+10.3%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$43.04 -
$46.81
Company Quality Score
51/100
(HOLD)
Options IV Signal
67th percentile
(NORMAL)
Volume Confirmation
HIGH
Confidence Score
57.1%
All Signals
- BEARISH: Price extended above range
- NEUTRAL: Options fairly priced (IV 67th percentile)
- NEUTRAL: Mixed technical signals (55/100)
- BULLISH: High volume confirmation
- BULLISH: Strong upward momentum (+4.3%)
- BULLISH: Trading below Wall St target ($51.60)
Trading Range Analysis
30-Day Trading Range
$43.04 -
$46.81
Current vs Trading Range
EXTENDED
Expected Move (7 Days)
±$16.49
(33.6%)
Support & Resistance Levels
Support Level
$43.41
Resistance Level
$48.57
Current Trend
Uptrend
Technical data as of
Aug 3, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-16.69
Wall Street Target
$51.60
(+10.3%)
Share & Embed Analysis
Last updated: August 03, 2026 2:49 PM ET
Data refreshes hourly during market hours. Next update: 3:49 PM
Data refreshes hourly during market hours. Next update: 3:49 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is SION showing a specific setup today?
Insider Activity (6 Months)
0
Buys
10
Sells
Net
INSIDERS SELLING
Recent Transactions
Peter A Thompson
SELL
2948 shares
2026-04-18
Orbimed Advisors Llc
SELL
2948 shares
2026-04-18
Orbimed Advisors Llc
SELL
52397 shares
2026-04-17
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
BMRN
Biomarin Pharmaceutical … |
STRONG BUY
29 analysts |
$88 | 53 HOLD |
|
DNLI
Denali Therapeutics Inc |
STRONG BUY
19 analysts |
$34 | 55 HOLD |
|
AXSM
Axsome Therapeutics Inc |
STRONG BUY
19 analysts |
$282 | 54 HOLD |
|
NRIX
Nurix Therapeutics Inc |
STRONG BUY
18 analysts |
$33 | 60 HOLD |
|
BBIO
BridgeBio Pharma Inc |
STRONG BUY
19 analysts |
$105 | 56 HOLD |
